https://www.pharmaceutical-technology.com/news/kailera-therapeutics-625m-biotech-ipo/ 2026-04-17T14:30:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aligos-xiamen-amoytop-hbv-therapy/ 2026-04-17T09:54:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-innovators-working-to-make-in-vivo-cell-therapy-a-reality/ 2026-04-17T15:47:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-interna-mnm-delivery-solutions/ 2026-04-17T10:16:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/developers-back-alzheimers-drugs-despite-report-suggesting-lack-of-efficacy/ 2026-04-16T15:29:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-requests-postmarketing-safety-studies-eli-lilly-foundayo/ 2026-04-16T14:29:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/terremoto-108m-series-c-cancer-rare-disease-programmes/ 2026-04-16T10:35:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nucleai-sirona-dx-proteomics-solution/ 2026-04-16T08:51:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-zai-lab-dual-dll3-therapy/ 2026-04-16T08:20:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-draft-guidance-genome-editing-gene-therapy/ 2026-04-15T15:03:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amazon-launches-ai-drug-discovery-platform/ 2026-04-15T14:58:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-q1-2026-earnings-pharma-oncology/ 2026-04-15T10:29:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adcendo-75m-funding-adc-development/ 2026-04-15T10:13:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-to-acquire-crossbridge-bio/ 2026-04-15T09:26:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-2025-pharma-import-export-statistics/ 2026-04-14T15:00:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-5-0-sustainability-security-pharmap-2026-brings-pharmas-future-into-focus/ 2026-04-14T13:24:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/advancing-pressure-protection-in-biopharma-how-integrated-bypass-technology-elevates-single-use-pump-design/ 2026-04-15T16:37:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/travere-therapeutics-fda-approval-sparsentan/ 2026-04-14T10:24:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-openai-drug-development-partnership/ 2026-04-14T10:00:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-daiichi-sankyos-ifinatamab-fda-priority/ 2026-04-14T10:09:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-haisco-745m-pain-drug-licensing-deal/ 2026-04-13T11:07:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telix-regeneron-radiopharmaceutical-therapies/ 2026-04-13T11:26:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-complete-response-letter-replimune-rp1/ 2026-04-13T10:23:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-oxford-biotherapeutics-tce-drug-discovery-partnership-interview/ 2026-04-10T16:32:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/emerging-therapies-frail-hnscc-patients/ 2026-04-10T13:35:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/advancing-single-cell-transcriptomics-into-the-mainstream-of-biomedical-research/ 2026-04-10T11:02:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-c4-therapeutics-degrader-antibody-conjugates/ 2026-04-10T09:39:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/precision-medicine-in-early-oncology-trials-biomarkers-as-strategic-drivers/ 2026-04-10T08:46:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gan-lee-jw-pharmaceutical-bofanglutide-commercialisation/ 2026-04-10T09:04:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eversea-to-acquire-hasten-biopharmaceuticals/ 2026-04-09T09:39:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-seeks-permanent-future-for-rare-pediatric-priority-review-vouchers/ 2026-04-09T09:27:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shionogi-secures-482m-barda-contract-antibiotic-antimicrobial-resistance/ 2026-04-09T09:07:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jeito-capital-new-biopharma-investments/ 2026-04-09T09:05:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sidewinder-therapeutics-137m-series-b-funding-bispecific-adcs/ 2026-04-08T14:40:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roosterbio-minebio-msc-solutions-china/ 2026-04-08T09:28:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-industry-laments-trumps-tariff-on-branded-drugs/ 2026-04-08T09:40:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/halozyme-vertex-deal-hypercon-technology/ 2026-04-08T09:12:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/why-timelines-break-down-in-rare-kidney-drug-development/ 2026-04-08T16:39:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-outlays-5bn-to-acquire-adc-specialist-tubulis/ 2026-04-07T14:42:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-approved-drug-manufacturing-deals-shifting-europe/ 2026-04-07T12:41:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apnimed-150m-funding-ad109-launch/ 2026-04-07T10:11:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-hidden-bottleneck-in-digital-healthcare-why-hospital-wireless-networks-are-under-pressure-in-2026/ 2026-04-08T09:54:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-evolving-landscape-of-subcutaneous-drug-administration/ 2026-04-07T08:56:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cgts-next-obstacle-securing-the-leukapheresis-supply-chain/ 2026-04-07T15:55:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/neurocrine-to-buy-soleno/ 2026-04-07T09:27:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aspect-biosystems-cellular-medicine-project/ 2026-04-06T09:12:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-ec-clearance-keytruda-combination/ 2026-04-06T07:52:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/hnscc-market-8mm-2034/ 2026-04-02T14:20:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-2026-sotatercept-meta-analysis-backs-disease-modifying-role-in-pah/ 2026-04-02T12:47:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-2026-cagrisema-superior-first-line-obesity-therapy-meta-analysis-2/ 2026-04-02T11:07:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-wins-fda-approval-for-weight-loss-pill-tees-up-novo-rivalry/ 2026-04-02T10:31:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-acquires-jsr-chromatography/ 2026-04-02T09:50:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocytogen-sihuan-advance-therapeutics-weight-loss/ 2026-04-02T09:50:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-2026-dulaglutide-coronary-plaque-stabilisation-t2d/ 2026-04-01T12:56:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-acquires-apellis-pharmaceuticals-5-6bn/ 2026-04-01T10:36:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-outlays-7-8bn-to-acquire-sleep-drug-biotech-centessa/ 2026-04-01T11:52:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/telomir-seeks-fda-approval-telomir-1/ 2026-04-01T09:39:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-2026-sotatercept-shows-signal-in-cpcph-hfpef-at-lower-dose/ 2026-04-01T13:37:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-2026-tonlamarsen-lowers-angiotensinogen-without-extra-bp-benefit/ 2026-04-01T09:27:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/symeres-ambagon-colorectal-cancer-molecules/ 2026-04-01T09:38:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/non-invasive-diagnostics-in-endometriosis-at-the-cusp-of-a-turning-point/ 2026-04-01T15:41:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-rise-of-adcs-in-oncology/ 2026-03-31T11:19:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/uk-life-sciences-navigating-commercial-gaps-pharma-biotech/ 2026-03-31T11:03:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-fda-approval-prolia-biosimilar/ 2026-03-31T10:45:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/blackstone-life-sciences-6-3bn-private-funding-pharma-medtech/ 2026-03-31T10:45:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ubrigene-cellinfinity-vivo-cart-therapies/ 2026-03-31T10:46:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-2026-baxdrostat-lowers-bp-in-uncontrolled-hypertension/ 2026-03-31T08:57:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/acc-2026-lorundrostat-lowers-bp-but-raises-hyperkalemia-risk/ 2026-04-14T14:19:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/from-compliance-to-culture-lessons-from-a-quality-leader-on-pharmas-next-imperative/ 2026-03-31T14:19:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-future-of-healthcare-in-america-what-to-expect-in-the-next-decade/ 2026-03-31T07:49:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-crucial-role-of-payload-linker-innovation-in-the-growth-of-adcs/ 2026-03-30T14:19:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/merck-acquires-terns-targeting-dominance-cml/ 2026-03-30T14:09:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/otsuka-to-acquire-transcend-therapeutics/ 2026-03-30T09:57:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-insilico-medicines-ai-rd-pact-2-75bn/ 2026-03-30T09:53:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-fda-approval-awiqli/ 2026-03-30T09:51:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/recordati-considers-cvc-acquisition-offer/ 2026-03-27T16:51:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/podcast-european-biotech-rallies-against-us-and-china-powerhouses/ 2026-03-27T16:03:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jjs-darzalex-nets-first-self-administered-cancer-injectable-approval/ 2026-03-27T15:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rockets-gene-therapy-kresladi-wins-fda-approval-in-rare-immune-disease/ 2026-03-27T11:44:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-to-acquire-excellergy-2bn/ 2026-03-27T11:33:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/simulations-pharma-ai-drug-development/ 2026-03-27T10:24:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/corcept-therapeutics-lifyorli-relacorilant-fda-approval-ovarian-cancer/ 2026-03-26T17:10:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-opens-door-to-feedback-on-unclear-national-priority-voucher-pathway/ 2026-03-26T11:30:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cognito-therapeutics-ochsner-brain-health-approaches/ 2026-03-26T10:37:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-tempus-adc-development/ 2026-03-26T10:05:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/most-favored-nation-policy-early-insights-into-europe-response/ 2026-03-31T12:07:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-2bn-georgia-gwinnett-county-biologics-manufacturing-facility/ 2026-03-25T15:34:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/improving-early-detection-treatment-liver-cancer/ 2026-03-25T15:33:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-spends-6-7bn-to-buy-terns-pharmaceuticals-in-cancer-pipeline-reinforcement/ 2026-03-25T14:49:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/researchers-become-scientific-tastemakers-by-handing-more-rnd-to-autonomous-labs/ 2026-03-25T11:16:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vizai-alnylam-advance-identification-cardiac-amyloidosis/ 2026-03-25T11:15:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-quotient-ibd-drug-targets/ 2026-03-25T10:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/gilead-doubles-down-on-cell-therapy-inside-the-7-8bn-arcellx-acquisition/ 2026-03-25T09:54:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-to-acquire-ouro-medicines-galapagos-gamgertamig-co-development/ 2026-03-24T16:32:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/what-to-consider-before-choosing-a-fast-track-healthcare-qualification/ 2026-03-31T07:42:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/monash-university-clinchoice-therapies-development/ 2026-03-24T10:26:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kali-sanofi-licence-agreement-kt501/ 2026-03-24T09:50:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/clinical-trials-are-data-managers-ready-for-ai-in-edc/ 2026-03-23T13:03:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/earendil-labs-787m-financing-ai-drug-discovery-development/ 2026-03-23T11:15:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunitybio-macau-approval-anktiva-combo/ 2026-03-23T10:23:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-fda-ec-approvals-opdivo/ 2026-03-23T09:57:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-wegovy-hd-high-dose-fda-approval/ 2026-03-20T16:52:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-to-acquire-snv4818-synnovation/ 2026-03-20T10:26:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/congruence-advance-small-molecule-correctors/ 2026-03-20T09:49:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-wins-fda-approval-for-icotyde-to-enter-psoriasis-pill-market/ 2026-03-20T09:30:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-and-nice-launch-aligned-pathway-for-faster-medicine-regulation/ 2026-03-19T11:23:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/quintessence-biotech-first-artificial-living-cell-cgt-manufacturing/ 2026-03-19T11:10:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/huntingtons-gene-therapy-research-has-reached-a-turning-point-expert-says/ 2026-03-19T10:54:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/calls-for-change-as-access-to-cell-and-gene-therapies-in-the-netherlands-falls-short/ 2026-04-08T16:31:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/excalipoint-therapeutics-chinese-biotech-seed-financing/ 2026-03-18T16:45:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-prepared-for-potential-expansion-of-meningitis-vaccine-schedule-amid-uk-outbreak/ 2026-03-18T12:04:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/navigating-the-biotech-valley-of-death-atmp-investor-perspective/ 2026-03-18T11:24:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/r1-therapeutics-progress-ap306-hyperphosphatemia/ 2026-03-18T09:58:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-crl-aldeyras-reproxalap-application/ 2026-03-18T09:32:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sanofi-mrna-car-t-enters-in-vivo-race/ 2026-03-17T17:32:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/autologous-allogeneic-cell-therapy-development-oncology/ 2026-03-19T14:56:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rfk-jrs-vaccine-overhaul-halted-by-federal-judges-ruling/ 2026-03-17T15:57:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-sun-pharmas-ilumya-sbla/ 2026-03-17T10:59:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sentynl-prg-progerinin-licence/ 2026-03-17T10:19:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/most-london-patients-go-private-to-access-weight-loss-drugs/ 2026-03-16T15:19:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-rsv-jab-arexvy-fda-label-expansion-high-risk-adults-18-49/ 2026-03-16T11:25:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fda-us-prescription-to-otc-shift-lies-in-pharmas-hands/ 2026-03-16T15:38:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biophytis-lynxkite-alliance-ai-drug-discovery/ 2026-03-16T10:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-fda-approval-cosentyx/ 2026-03-16T09:58:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/parkinsons-uk-david-dexter-drug-development-clinical-trials/ 2026-03-13T12:20:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/nine-ways-to-ensure-a-reliable-technology-transfer/ 2026-03-16T15:46:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-directs-antibiotic-development-to-priority-pathogens/ 2026-03-13T11:36:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/prism-biolab-receptorai-molecule-discovery/ 2026-03-13T10:45:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/psiquantum-national-cancer-center-quantum-computing/ 2026-03-13T10:47:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vima-therapeutics-series-a-financing-parkinsons-dystonia-vim0423/ 2026-03-13T16:37:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-finds-impurity-in-compounded-tirzepatide/ 2026-03-13T16:51:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/wegovy-portfolio-growth-pill/ 2026-03-12T14:22:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordic-sii-vaccine-production/ 2026-03-12T11:21:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/curatis-neupharma-agreement-corticorelin-japan/ 2026-03-12T11:16:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-fda-warning-letter-semaglutide-adverse-event-reporting/ 2026-03-11T18:01:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/tariffs-uncertainty-and-disruption-how-drug-makers-and-distributors-can-build-supply-chain-resilience/ 2026-03-11T15:15:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-to-invest-3bn-in-china-in-anticipation-of-orforglipron-approval/ 2026-03-11T14:31:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biontech-co-founders-step-down-to-launch-new-mrna-venture/ 2026-03-11T13:44:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-funding-infectious-disease-clinical-trials-africa-south-east-asia/ 2026-03-11T11:19:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/idorsia-pharmalink-deal-to-distribute-quviviq/ 2026-03-11T10:51:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-gsk-wellcovorin/ 2026-03-11T10:22:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/peptides-in-the-pipeline-early-stage-challenges/ 2026-03-10T16:29:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-vaccine-manufacturers-rfk-weaker-vaccine-mandates/ 2026-03-10T14:47:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-fda-draft-guidance-biosimilar-development-pharmacokinetic-studies/ 2026-03-10T14:46:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/building-for-decades-dubais-long-game-in-life-sciences-2/ 2026-03-14T06:33:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/junshi-chinas-nmpa-toripalimab-injection/ 2026-03-10T10:44:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-and-hims-hers-become-partners-to-end-legal-feud/ 2026-03-10T10:41:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/newcelx-eledon-ncel-101-programme/ 2026-03-10T10:13:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/globaldata-key-thoughts-world-epa-congress-2026/ 2026-03-09T15:00:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-sells-liver-disease-drug-candidate-to-alfasigma-for-690m/ 2026-03-09T11:35:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vinay-prasad-to-leave-fda-again-cber/ 2026-03-09T11:32:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sciwind-chinas-nmpa-approval-ecnoglutide/ 2026-03-09T10:42:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-fda-approval-sotyktu/ 2026-03-09T10:27:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/multiple-myeloma-awareness-month/ 2026-03-06T17:33:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/women-first-the-gulfs-new-healthcare-blueprint/ 2026-03-09T08:50:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alnylam-tenaya-heart-disease-target-identification-deal/ 2026-03-06T11:27:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-tecvayli-darzalex-combo-fda-approval/ 2026-03-06T11:12:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-the-ai-shift-is-happening-now-in-data-management/ 2026-03-06T10:47:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/liberate-bio-licences-myeloid-car/ 2026-03-06T10:55:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-settles-patent-infringement-lawsuit-2-25bn-genevant-arbutus/ 2026-03-05T16:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/targeted-therapies-chemotherapy-cancer-treatment-paradigm/ 2026-03-05T15:08:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cordenpharma-flatiron-park-peptides-development/ 2026-03-05T10:46:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-biopharma-is-scaling-sterile-manufacturing-in-2026/ 2026-03-16T12:14:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/globaldata-main-market-lse-2/ 2026-03-05T11:33:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/affinia-fda-fast-track-designation/ 2026-03-05T10:06:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-1-5bn-licensing-deal-sino-biopharm-rovadicitinib-gvhd/ 2026-03-04T18:02:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aspire-microsize-alprazolam-powder-formulation/ 2026-03-04T11:13:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/esperion-to-acquire-corstasis-cardiovascular/ 2026-03-04T10:25:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/extracellular-vesicles-the-next-frontier-in-regenerative-medicine-and-drug-delivery/ 2026-03-04T17:22:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/navigating-uncertainty-and-building-resilient-supply-chains-the-case-for-us-based-cdmo-partnerships/ 2026-03-04T09:40:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ose-immunotherapeutics-narrows-pipeline-focus-late-stage-assets/ 2026-03-03T17:27:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-rings-the-changes-as-ceo-shake-up-continues/ 2026-03-03T16:48:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/europes-pharma-trade-with-the-us-remains-critical-despite-tariff-turmoil/ 2026-03-03T15:53:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rallybio-to-acquire-candid-therapeutics/ 2026-03-03T11:29:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-starts-e432m-ireland-facility-upgrade-for-oral-wegovy-production/ 2026-03-03T11:08:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kairos-pharma-celyn-therapeutics-deal/ 2026-03-03T10:23:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/dermatology-trials-by-the-numbers-key-trends-and-benchmarks-for-2026/ 2026-03-03T10:10:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-covid-flu-combination-vaccine-chmp-positive-opinion-ema/ 2026-03-02T17:16:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-ascendis-pharmas-weekly-yuviwel-for-paediatric-dwarfism/ 2026-03-02T11:04:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-chmp-recommendation-dupixent-expansion/ 2026-03-02T14:53:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biomarin-fda-approval-palynziq-use/ 2026-03-02T09:58:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-americas-former-steel-heartland-secured-a-3-5bn-eli-lilly-facility/ 2026-03-02T09:11:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ingelheim-sitryx-licensing-deal-hernexeos-frontline-nsclc-approval/ 2026-02-27T16:04:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cinnagen-enters-eu-market-with-ema-approval-for-zandoriah/ 2026-03-04T19:47:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/generate-biomedicines-secures-400m-ipo-in-flurry-of-february-listings/ 2026-02-27T12:23:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/asahi-kasei-aicuris-antiinfective-cures/ 2026-02-27T11:13:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/podcast-rare-disease-day-fda-guidance-allowing-advancement/ 2026-02-27T12:45:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/quotient-ipsen-extend-partnership-fop/ 2026-02-27T10:58:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/rare-disease-developers-applaud-clarity-in-fda-guidance/ 2026-03-02T17:15:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/nonprofit-models-support-strategic-boldness-to-develop-gene-therapies-for-rare-diseases/ 2026-02-27T11:08:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-and-police-seize-2000-illegal-weight-loss-drugs-after-raiding-criminal-facility/ 2026-02-26T11:31:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iqvia-acquire-charles-river-assets/ 2026-02-26T10:43:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-vivtex-medicines-development/ 2026-02-26T09:41:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-acquires-35pharma-cardiopulmonary-diseases-hs235/ 2026-02-25T16:39:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rfk-jr-faces-legal-challenge-from-15-us-states-over-childhood-vaccine-recommendations/ 2026-02-25T11:27:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/slate-medicines-funding-pacap-treatments/ 2026-02-25T11:16:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/northx-biologics-demeetra-gmp-manufacturing/ 2026-02-25T10:05:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gene-editing-takes-centre-stage-in-fdas-new-rare-disease-approval-pathway/ 2026-02-24T11:03:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-frontier-biotechnologies-sirna-licensing-deal/ 2026-02-24T10:45:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-beren-therapeutics-nda/ 2026-02-24T10:14:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-investment-north-chicago-api/ 2026-02-24T09:46:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-acquires-car-t-specialist-arcellx-for-7-8bn/ 2026-03-11T13:22:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-pledges-e225m-to-develop-next-generation-of-flu-vaccines/ 2026-02-23T14:24:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-board-shakeup-election-recommendations/ 2026-02-23T11:39:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazenecas-calquence-venetoclax-us-approval/ 2026-02-23T10:57:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/podcast-which-pharma-and-medtech-companies-came-out-on-top-in-2025-revenues/ 2026-02-23T10:51:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-receives-fda-acceptance-giredestrant/ 2026-02-23T10:32:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/altesa-biosciences-75m-financing-copd-rhinovirus-antiviral-vapendavir/ 2026-02-20T17:37:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-wants-improved-universal-vaccines-to-win-global-influenza-battle/ 2026-02-20T11:42:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ingelheim-niper-mou-pharmaceutical/ 2026-02-20T10:28:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/syngene-vivamed-therapeutic-programmes/ 2026-02-20T10:11:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valnevas-lyme-disease-vaccine-offers-beacon-of-hope-amid-2025-sales-dip/ 2026-02-19T15:00:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-1bn-cell-therapy-manufacturing-site-pennsylvania/ 2026-02-19T11:02:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-enters-licensing-agreement-unp/ 2026-02-19T10:17:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-mayo-ai-drug-development/ 2026-02-19T10:13:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-to-review-moderna-seasonal-flu-vaccine-mrna-1010/ 2026-02-18T17:02:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-expands-injectable-wegovy-offering-with-european-higher-dose-approval/ 2026-02-18T15:01:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/evogene-qut-ai-cancer-therapies/ 2026-02-18T10:12:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/the-china-factor-us-pharma-group-campaigns-for-increased-competitiveness/ 2026-02-18T12:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jjs-rybrevant-faspro-fda-approval/ 2026-02-18T10:15:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sle-ln-market-7mm-by-2034/ 2026-02-17T16:51:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/rna-targeting-small-molecules-a-new-frontier-of-drug-discovery/ 2026-02-17T16:10:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/globaldata-pharma-sector-drug-pricing-challenges/ 2026-02-17T15:57:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pharma-companies-venture-further-afield-in-search-of-rd/ 2026-02-17T15:36:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teijin-aska-gynaecological-drug-development/ 2026-02-17T10:18:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/excellthera-german-nub-status-zemcelpro/ 2026-02-17T09:43:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-builds-orforglipron-cache-to-avoid-previous-glp-1ra-shortages/ 2026-02-16T16:02:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ptc-therapeutics-withdraws-translarna-dmd-nda/ 2026-02-16T15:55:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/oeb-6-the-new-standard-in-high-potent-molecule-manufacturing/ 2026-02-16T15:32:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-crl-disc-medicines-bitopertin/ 2026-02-16T10:48:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/immunic-fund-commercial-stage-development/ 2026-02-16T10:18:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/theranostic-radiopharmaceuticals-future-of-radiopharma/ 2026-02-25T11:25:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-vc-firms-band-together-to-tackle-continents-lacklustre-capital/ 2026-02-13T16:17:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abpi-preclinical-testing-framework-academic-industry-collaboration/ 2026-02-13T15:26:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/significant-opportunities-global-pain-market/ 2026-02-13T15:07:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ampersand-capital-acquires-purna-pharmaceuticals/ 2026-02-13T10:49:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-ec-approval-uplizna-gmg/ 2026-02-13T10:19:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/market-instability-expected-south-korea-new-pricing-reform/ 2026-02-12T17:33:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-replaces-ceo-paul-hudson-with-outgoing-merck-kgaa-head/ 2026-02-12T17:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/madrigal-pharmaceuticals-4-4bn-mash-sirna-licensing-deal/ 2026-02-12T15:43:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/citius-oncology-uniphar-european-deal/ 2026-02-12T10:55:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-fda-approval-keytruda-combo/ 2026-02-12T10:10:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mexico-enlists-moderna-to-boost-mrna-supply-for-respiratory-diseases/ 2026-02-11T17:33:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-declines-to-review-moderna-flu-vaccine-mrna1010/ 2026-02-11T16:18:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-expects-6-of-hiv-sales-growth-in-2026-with-800m-yeztugo-target/ 2026-02-11T12:11:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/thx-pharma-biocodex-drugs-deal/ 2026-02-11T10:16:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insilico-cms-drug-discovery-cns/ 2026-02-11T10:04:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-bets-on-continued-oncology-demand-for-2026-growth/ 2026-02-10T16:02:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/abbvie-100bn-deal-domestic-manufacturing/ 2026-02-10T14:29:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/rwd-and-rwe-are-rewriting-how-we-design-and-run-trials/ 2026-02-10T14:05:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/a-new-strategic-blueprint-designing-smarter-early-phase-trials-in-oncology/ 2026-02-10T11:05:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/by-the-numbers-oncology-trial-activation-timelines-and-global-reach/ 2026-02-10T10:19:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regenxbio-fda-response-rgx121-application/ 2026-02-10T10:15:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-iambic-small-molecule-programmes/ 2026-02-10T09:39:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-acquires-orna-therapeutics-in-vivo-car-t-2-4bn/ 2026-02-09T17:00:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-sues-hims-hers-despite-wegovy-pill-offering-u-turn/ 2026-02-09T15:30:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-future-of-robots-in-pharma-logistics/ 2026-02-10T08:48:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-eyes-ai-deals-to-stem-lost-revenues-from-patent-expirations/ 2026-02-10T10:10:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/fdas-commissioner-vouchers-prompt-questions-about-award-process/ 2026-02-09T11:41:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-smart-and-connected-packaging/ 2026-02-09T11:38:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovent-lilly-oncology-immunology-medicines/ 2026-02-09T10:01:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-construction-facility-san-diego/ 2026-02-09T09:36:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trumprx-launches-to-slash-drug-prices-for-cash-paying-us-patients/ 2026-02-06T15:58:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/originator-medicines-list-prices-us/ 2026-02-06T13:27:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-targets-illegal-drug-copies-amid-latest-hims-hers-novo-nordisk-flashpoint/ 2026-02-06T11:22:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/1bn-london-cancer-hub-expansion-approval-uk-life-sciences/ 2026-02-06T11:12:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-flat-revenue-growth-2025/ 2026-02-06T10:48:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/apotex-grunenthal-nebido-canadian-distribution/ 2026-02-06T10:06:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rare-paediatric-disease-voucher-programme-makes-long-awaited-us-return/ 2026-02-05T19:37:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-henlius-serplulimab-licensing-deal-japan-anti-pd-1-oncology/ 2026-02-05T17:37:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/everest-medicines-micot-mt1013-commercialisation/ 2026-02-05T10:32:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/research-reports/j-p-morgan-healthcare-conference-2026-report/ 2026-02-05T15:52:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/primegen-dt-cloud-star-agreement/ 2026-02-05T09:50:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-fy2025-financial-results-hiv-oncology/ 2026-02-04T19:01:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-soars-past-expectations-to-hit-45-sales-growth-in-2025/ 2026-02-04T17:38:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/why-pharma-manufacturers-are-still-investing-in-europe/ 2026-02-25T09:49:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-shares-tumble-18-after-2026-sales-dip-warning/ 2026-02-04T13:28:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/relay-therapeutics-zovegalisib-fda-btd/ 2026-02-04T10:35:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cepi-samsung-biologics-global-vaccine/ 2026-02-04T10:30:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-fy25-results-future-directions-obesity-ai/ 2026-02-03T17:59:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msds-2026-sales-forecast-falls-short-amid-patent-losses-despite-strong-q4/ 2026-02-03T16:41:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-driving-linked-data-insights-the-complexities-and-experiences/ 2026-02-05T14:52:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanegenebio-genentech-global-licensing-deal/ 2026-02-03T10:38:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aquestive-fda-crl-anaphylm/ 2026-02-03T09:58:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/pharmaceutical-technology-excellence-awards-2025-pharma-major-lupin-wins-two-awards/ 2026-03-16T15:46:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-selects-pennsylvania-for-3-5bn-obesity-drugs-manufacturing-site/ 2026-02-02T16:33:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/pharmaceutical-technology-excellence-awards-2025-cellular-origins/ 2026-03-17T11:14:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-rocatinlimab-kyowa-kirin-agreement-termination-atopic-dermatitis/ 2026-02-02T11:03:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chmp-positive-opinion-jjs-akeega/ 2026-02-02T10:51:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cirm-rapid-funding-programme/ 2026-02-02T10:28:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fdas-new-scheme-to-boost-us-manufacturing-commences-despite-uncertainty/ 2026-01-30T23:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-fy2025-sales-results/ 2026-01-30T11:56:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-signs-18-5bn-weight-loss-drug-deal-with-cspc/ 2026-01-30T11:49:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iqvia-boehringer-ingelheim-therapeutic-data/ 2026-01-30T10:53:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/repertoire-lilly-autoimmune-disease-therapies/ 2026-01-30T10:02:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-china-drug-randd-manufacturing-investment/ 2026-01-29T15:20:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-2025-profit-blunted-by-weakened-us-dollar/ 2026-01-29T14:57:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sensorion-reserved-offering-gene-therapy/ 2026-01-29T10:00:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-status-biogens-litifilimab-cle/ 2026-01-29T09:55:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-outlays-1-12bn-for-hearing-loss-gene-therapy-partnership/ 2026-01-28T16:40:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/real-world-evidence-and-healthcare/ 2026-01-28T16:17:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pharma-fulfilment-is-your-software-up-to-the-challenge/ 2026-01-28T17:30:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/eliquis-sales-forecast-to-plummet/ 2026-01-28T14:50:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cms-selects-next-batch-of-15-high-cost-medicines-for-third-negotiation-cycle/ 2026-01-28T11:49:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accepts-otsukas-centanafadine-application/ 2026-01-28T10:34:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insilico-qilu-pharmaceutical-sign-deal/ 2026-01-28T09:50:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-and-certain-european-countries-lose-whos-measles-free-status/ 2026-01-27T15:22:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mirum-acquires-bluejay-therapeutics/ 2026-01-27T10:33:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-review-eisais-leqembi-sbla/ 2026-01-27T10:17:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/internet-of-medical-things-beats-ai-as-top-ranked-growth-driver-among-life-science-ceos/ 2026-01-26T16:21:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-biotechs-suffered-restricted-financing-in-2025/ 2026-01-26T13:57:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-ends-takeover-talks-with-revolution-medicines/ 2026-01-26T17:53:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-nice-recommends-pfizer-talzenna-metastatic-prostate-cancer/ 2026-01-26T11:09:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/corxel-raises-287m-as-obesity-continues-to-spark-investor-interest/ 2026-01-23T11:37:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/phillips-medisize-high-dose-biologic-drug-delivery/ 2026-01-27T11:25:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/daiichi-sankyo-astrazenecas-enhertu-approval/ 2026-01-23T12:36:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-janux-therapeutics-850m-solid-tumour-oncology-licensing-deal/ 2026-01-22T17:02:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-set-to-officially-exit-who-in-culmination-of-trumps-domestic-push/ 2026-01-22T16:51:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/the-new-safety-mandate-driving-ai-ready-pharmacovigilance/ 2026-01-20T17:14:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aha-2026-cardiovascular-disease-report-heart-disease-stroke/ 2026-01-22T12:29:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-reports-sales-q4/ 2026-01-22T10:03:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/opna-bios-opn2853-fdas-status/ 2026-01-22T10:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/davos26-trump-says-tariff-threats-helped-fix-us-drug-pricing-unfairness/ 2026-01-21T17:04:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/walking-the-pharma-supply-chain-tightrope-requires-more-than-precision/ 2026-01-23T14:40:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/compliance-and-clinical-trials-logistics/ 2026-01-21T14:42:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-novavax-530m-deal-matrix-m-vaccine-adjuvant/ 2026-01-21T11:25:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-microsoft-partner-cancer-detection/ 2026-01-21T10:21:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-aspect-biosystems-therapies/ 2026-01-21T10:00:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/innovations-in-dermatology-trials-embracing-digital-tools-and-decentralized-approaches/ 2026-01-20T17:15:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/when-trillion%e2%80%91member-libraries-meet-physics-what-diversity-really-means/ 2026-01-21T16:15:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shionogi-expands-viiv-healthcare-stake-by-2-13bn-as-pfizer-sells-up/ 2026-01-20T16:14:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/uk-us-zero-tariff-deal-hub-medicines/ 2026-01-20T14:42:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/excellence-in-focus/ai-empathetic-pharma-field-training-acto/ 2026-03-17T11:02:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-rapt-therapeutics-acquisition-2-2bn-immunology-food-allergy/ 2026-01-20T12:33:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/deephow-pharmacloud-pharmaceutical-manufacturers/ 2026-01-20T10:15:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iregene-receives-fda-rmat-designation/ 2026-01-20T09:57:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uks-pharma-outlook-buoyed-by-trans-atlantic-trade-policies/ 2026-01-19T16:48:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-immunocore-signals-entry-into-type-1-diabetes/ 2026-01-20T14:45:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-atea-pharmaceuticals-outlines-hcv-strategy-centred-on-short-duration-regimens/ 2026-01-19T15:27:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/transformative-arrival-of-oral-weight-loss-medicines-in-us/ 2026-01-19T14:38:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/compounder-sues-lilly-and-novo-for-suppressing-glp-1ra-competition/ 2026-01-19T14:25:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analysis/podcast-jpm26s-dealmaking-falls-short-of-expectations/ 2026-01-19T14:17:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-acquire-abelzetas-cart-therapy/ 2026-01-19T10:17:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-novartis-ianalumab-breakthrough-status/ 2026-01-19T10:28:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ema-2025-drug-approvals-rare-disease/ 2026-01-16T17:52:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jjs-caplyta-doubles-remission-rate-in-mdd-patients/ 2026-01-16T16:58:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-mhra-approves-wegovy-7-2mg-obesity-weight-loss/ 2026-01-16T16:18:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-dealmaking-optimism-at-jpm-2026-despite-absence-of-mega-mas/ 2026-01-16T15:28:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-abbvie-highlights-growth-drivers-as-it-moves-away-from-humira-dependency/ 2026-01-16T12:53:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-advantages-of-a-platform-approach-in-clinical-trial-data-management/ 2026-01-16T14:34:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/interax-alveus-collaborate-metabolic-treatment/ 2026-01-16T10:02:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agenus-zydus-complete-141m-deal/ 2026-01-16T09:26:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-matrix-m-technology-is-central-to-novavaxs-strategy/ 2026-01-15T22:19:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-enanta-outlines-strategy-to-lead-in-rsv-therapeutics/ 2026-01-15T21:39:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-fujifilms-modular-manufacturing-answer-to-pharma-tariffs/ 2026-01-15T17:02:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-solid-biosciences-banks-on-its-aav-capsid-to-catalyse-gene-therapy-success/ 2026-01-15T16:58:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-foundation-850m-grant-bii-european-life-sciences/ 2026-01-15T16:45:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-jazz-sells-prv-for-200m-targets-deals-in-2026/ 2026-01-15T16:41:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-eli-lilly-obesity-drugs/ 2026-01-15T13:42:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-ema-ai-guidance-pharma-drug-development/ 2026-01-15T11:26:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-bi-multispecific-modalities-power-wuxi-biologics-growth/ 2026-01-15T10:33:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/big-pharma-and-investors-re-engage-in-cgts-and-race-to-scale/ 2026-01-22T09:41:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-novo-nordisk-reshapes-its-strategy-under-new-ceo/ 2026-01-15T03:14:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-eli-lilly-enters-2026-with-strong-momentum-given-pipeline-innovation/ 2026-01-15T03:06:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-vor-bio-narrows-focus-to-two-indication-strategy/ 2026-01-15T00:51:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-wuxi-apptec-drives-growth/ 2026-01-15T09:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-regeneron-will-not-overpay-in-ma-deals-amid-lead-asset-patent-expiries/ 2026-01-14T18:12:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-bayer-evades-patent-cliff-in-a-way-it-may-not-be-able-to-repeat/ 2026-01-14T17:52:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-astrazeneca-bids-to-accelerate-oncology-rd-with-modella-ai-acquisition/ 2026-01-14T17:21:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drugmakers-welcome-fdas-glp-1ra-suicide-warning-removal-request/ 2026-01-14T16:55:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-tryngolza-set-to-become-first-wholly-owned-ionis-blockbuster/ 2026-01-14T12:02:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-2025-a-breakout-year-for-rare-disease-biotechs/ 2026-01-14T12:00:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-biontech-gears-up-for-multiproduct-oncology-status-by-2030/ 2026-01-14T12:00:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-amgen-maritide-obesity-t2d-phase-ii/ 2026-01-14T12:59:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bd-110m-expand-syringe-production/ 2026-01-14T10:01:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fortress-biotech-fda-approval-zycubo/ 2026-01-14T09:28:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/doubling-down-on-efficacy-exploring-the-potential-of-dual-payload-adcs/ 2026-01-23T09:27:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-madrigal-seeks-early-dominance-in-mash-through-strategic-acquisitions/ 2026-01-13T23:25:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-thermofisher-very-positive-on-strategic-ma-as-deals-expand-capabilities/ 2026-01-13T22:44:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-gsk-banks-on-recent-ai-deals-to-offset-patent-expiries/ 2026-01-13T18:59:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-pfizers-metsera-deal-supercharges-its-obesity-strategy/ 2026-01-13T22:44:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-sanofi-demonstrates-significant-strategic-progress-with-several-novel-drugs/ 2026-01-13T17:06:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-illumina-billion-cell-atlas-drug-discovery-dataset/ 2026-01-13T17:25:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/trends-for-2026-targeted-ai-continuous-trials-and-navigating-uncertainty/ 2026-01-13T16:25:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-novartis-strengthens-neuroscience-portfolio-with-bolt-on-deals/ 2026-01-13T15:43:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-jj-leans-on-immunology-launches-to-fuel-annual-growth/ 2026-01-15T09:51:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/jpm26-jj-reveals-oncology-strategy/ 2026-01-13T15:13:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-vertex-hopes-to-match-cystic-fibrosis-success-in-pain-and-kidney-disease/ 2026-01-13T14:25:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/a-truly-global-pharmaceuticals-3pl-provider/ 2026-01-13T13:25:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-msd-merck-derisking-sales-strategy/ 2026-01-13T12:47:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-sarepta-ceo-touts-avalanche-of-elevidys-data-amid-2025-safety-woes/ 2026-01-13T12:08:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-hiv-pipeline-dosing-optionality-gives-gilead-advantage/ 2026-01-13T11:49:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-mfn-us-drug-pricing-deal-trump-randd-commitment/ 2026-01-13T11:20:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/vertically-integrated-cdmos-the-advantages-and-disadvantages-for-adcs/ 2026-02-13T12:09:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-bms-places-confidence-in-core-pipeline-to-weather-2030-patent-cliff/ 2026-01-13T10:34:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/scineuro-novartis-global-licensing-deal/ 2026-01-13T14:19:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drug-prices-and-policy-changes-drive-the-agenda-at-jpm26/ 2026-01-13T16:29:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/potency-assays-in-cell-therapies-a-look-behind-the-challenges/ 2026-01-13T09:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atara-fda-complete-response-letter/ 2026-01-13T09:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-anthropic-advances-healthcare-presence-with-new-ai-toolkit-2/ 2026-01-12T17:25:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/emerging-trends-in-real-world-data-and-ais-expanding-role/ 2026-01-12T16:58:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-eli-lilly-and-nvidia-deepen-ties-with-1bn-ai-partnership/ 2026-01-12T16:55:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-remegen-pd-1-vegf-bispecific-licensing-deal/ 2026-01-12T22:51:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-eli-lilly-reportedly-eyes-e15bn-takeover-of-abivax/ 2026-01-12T15:17:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-increases-manufacturing-flexibility-for-cell-and-gene-therapies/ 2026-01-12T12:31:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-value-of-real-world-data-for-healthcare-marketing/ 2026-01-12T12:15:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jpm26-revolution-medicines-in-spotlight-as-industry-gears-up-for-dealmaking-spree/ 2026-01-12T12:23:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-fourth-radioligand-therapy-facility/ 2026-01-12T11:01:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medilink-roche-exclusive-licensing-agreement/ 2026-01-12T09:38:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/us-pricing-models-under-mfn-strategy/ 2026-01-09T14:28:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/managing-supply-chain-challenges-for-cdmos/ 2026-02-12T16:44:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alveus-debuts-in-obesity-arena-with-160m-series-a/ 2026-01-09T11:47:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-mfn-drug-pricing-deal-branded-medicines/ 2026-01-09T11:23:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-halozyme-global-agreement-enhanze/ 2026-01-09T10:56:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/bile-acid-modulators-in-discovery-identifying-cholestasis-candidates-with-the-best-chance-of-success/ 2026-01-09T10:53:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/santhera-grants-agamree-rights-nxera/ 2026-01-09T09:49:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-acquires-inflammatory-specialist-ventyx-for-1-2bn/ 2026-01-08T11:05:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-to-file-for-approval-of-twice-yearly-hep-b-drug-on-positive-phase-iii-data/ 2026-01-14T11:54:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/octapharma-fda-approval-fibryga-formulation/ 2026-01-08T10:29:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/day-one-mersana-therapeutics-acquisition/ 2026-01-08T09:56:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-acquires-dark-blue-therapeutics-oncology-targeted-protein-degrader/ 2026-01-07T11:51:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-signs-1-3bn-obesity-focused-research-deal-with-nimbus/ 2026-01-07T11:49:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cellenkos-fda-orphan-drug-status/ 2026-01-07T10:57:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zai-labs-augtyro-nmpa-approval/ 2026-01-07T10:23:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cdc-shortens-routine-us-childhood-vaccination-schedule/ 2026-01-06T13:28:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-protagonist-fda-approval-rusfertide/ 2026-01-06T11:18:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aktis-oncology-kicks-2026-ipo-cycle-off-with-210m-target/ 2026-01-06T10:38:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/healthcares-biggest-2025-trends-and-2026-predictions/ 2026-01-06T10:29:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arrowhead-health-canada-authorisation/ 2026-01-06T11:17:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-earendil-labs-2-56bn-autoimmune-development-deal/ 2026-01-06T09:08:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/perfectly-harmonising-granulation-coating-processes/ 2026-01-09T14:57:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insilico-servier-oncology-research-agreement/ 2026-01-05T13:00:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogens-tysabri-to-be-used-on-englands-nhs-for-highly-active-ms/ 2026-01-05T11:24:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-bioepis-byooviz-commercialisation-europe/ 2026-01-05T13:01:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valneva-takes-back-charge-of-chikungunya-vaccine-supply-in-asia/ 2026-01-02T15:18:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/small-granulation-lines-rapid-change/ 2026-01-09T15:00:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/china-2025-nrdl-first-commercial-insurance-drug-list/ 2026-01-02T10:59:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/outlook-therapeutics-fda-response/ 2026-01-02T12:27:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-vanda-pharmaceuticals-motion-sickness-drug-nereus/ 2025-12-31T12:53:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emmaus-nit-endari-agreement/ 2025-12-31T10:20:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genmab-shelves-phase-iii-lung-cancer-candidate/ 2025-12-31T08:40:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/how-one-us-state-is-tackling-the-drug-affordability-crisis/ 2025-12-30T04:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-acquires-halda/ 2025-12-31T09:07:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/enriched-patient-data-needed-to-uncover-sex-differences-in-alzheimers-trials/ 2025-12-29T15:07:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-buys-hep-b-vaccine-maker-for-2-2bn/ 2025-12-29T14:58:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/revamping-best-selling-drugs-to-combat-patent-cliff-has-limits/ 2025-12-23T11:50:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovent-nmpa-approval-tabosun/ 2025-12-31T09:07:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-sciences-repares-rp-3467/ 2025-12-26T10:25:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zydus-bioeq-commercialisation-nufymco/ 2025-12-25T02:56:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/alternative-commercialisation-model-gene-therapy-ultra-rare-disease/ 2026-01-05T21:19:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/age-related-macular-degeneration-7mm-2034/ 2026-01-02T09:25:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-outlays-1bn-for-china-based-simceres-preclinical-adc/ 2025-12-23T11:54:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-biopharma-2025-ma-boom/ 2025-12-23T11:47:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genentech-approval-lunsumio-velo-sc/ 2025-12-23T10:55:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-beats-lilly-to-first-fda-approved-glp-1ra-pill-for-obesity/ 2025-12-23T10:37:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/samsung-biologics-human-genome-sciences/ 2025-12-23T09:07:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-positions-itself-for-2026-amid-an-evolving-us-landscape/ 2025-12-22T17:15:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biomarin-acquires-amicus-therapeutics-4-8bn-rare-disease/ 2025-12-22T16:28:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-approves-gileads-twice-yearly-hiv-prep-drug/ 2025-12-22T15:42:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-administration-ties-pricing-deals-with-another-nine-pharma-companies/ 2025-12-22T11:43:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cytokinetics-fda-approval-myqorzo/ 2025-12-22T12:22:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-andexxa-us-market-discontinuation-fda-safety-concerns/ 2025-12-22T10:38:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medipost-teikoku-seiyaku-partner/ 2025-12-22T10:57:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2025-tech-mahindra/ 2025-12-31T15:37:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/transforming-us-drug-access-production-mfn-pricing-deals-historic-manufacturing-investments/ 2025-12-19T14:53:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nxera-seeks-schizophrenia-programme-buyer-after-boehringer-snub/ 2025-12-19T14:44:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-to-seek-approval-of-plaque-psoriasis-pill-on-phase-iii-trial-data/ 2025-12-19T11:39:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-orforglipron-phase-iii-obesity-weight-maintenance-trial/ 2025-12-19T11:39:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-call-for-evidence/ 2025-12-19T11:10:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-receives-fda-approval/ 2025-12-19T09:20:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pfizer-depo-provera-contraceptive-label-change-meningiomas/ 2025-12-18T16:47:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biosecure-act-set-for-trumps-signature-after-congress-approval/ 2025-12-18T14:45:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incyte-minjuvi/ 2025-12-18T11:23:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alnylam-250m-norton/ 2025-12-18T09:24:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cdc-ends-universal-newborn-hepatitis-b-vaccine-recommendations/ 2025-12-17T15:57:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-exdensur-depemokimab-fda-approval-severe-asthma/ 2025-12-17T11:21:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/harbour-biomed-bms/ 2025-12-17T11:12:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/precision-medicine-approaches-needed-in-oncology-to-match-evolving-soc/ 2025-12-17T10:54:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/incog-indiana-us/ 2025-12-17T09:27:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2025-cellular-origins/ 2025-12-31T15:37:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/states-consider-payment-limits-to-curb-prescription-drug-prices/ 2025-12-17T11:35:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2025-bostongene/ 2025-12-31T15:37:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-signs-pair-of-billion-dollar-biotech-deals-to-bolster-pipeline/ 2025-12-16T17:58:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-fy-2025-2026-profit-forecast-guidance/ 2025-12-16T17:39:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pharma-ma-deal-value-2025-ytd-mega-deals/ 2025-12-16T17:01:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/the-hidden-crisis-in-regenerative-medicine/ 2025-12-16T11:54:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/transforming-medical-imaging-in-scotland-with-ai/ 2025-12-16T10:58:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leo-ema-anzupgo/ 2025-12-16T11:57:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/china-pharma-licensing-deals-oncology-innovative-drugs/ 2025-12-16T15:21:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sk-capital-swixx/ 2025-12-16T09:20:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-akeega-mcspc-prostate-cancer-fda-approval/ 2025-12-16T16:50:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/first-gonorrhoea-antibiotics-in-decades-herald-new-era-of-treatment/ 2025-12-15T16:43:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-shares-fall-6-after-double-setback-for-ms-drug-tolebrutinib/ 2025-12-15T11:49:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/acadia-daybue-stix/ 2025-12-15T10:14:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sobi-gout-arthrosi/ 2025-12-15T09:18:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-inches-closer-to-new-pharma-legislation-amid-competitiveness-drive/ 2025-12-12T15:59:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/biopharmas-2025-ma-boom-dealmaking-surges-as-patent-pressures-intensify/ 2025-12-12T16:06:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-sanofi-haematologic-disease/ 2025-12-12T11:21:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zealand-otr-metabolic-disease/ 2025-12-12T09:38:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-relation-target-discovery-deal-atopic-diseases/ 2025-12-12T17:06:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-signs-deal-worth-up-to-503m-with-nanexa/ 2025-12-11T16:50:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-government-drug-spending-vpag-rebate-2026/ 2025-12-11T15:09:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-switzerland-jobs/ 2025-12-11T14:10:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-boehringer-jascayd/ 2025-12-11T10:34:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/formation-bio-lynk/ 2025-12-11T09:53:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/crenolanib-incremental-benefit-flt3-npm1-co-mutated-aml/ 2025-12-10T15:34:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cell-and-gene-therapy-investment-strategy-pivots-as-funding-dries-up/ 2025-12-10T11:46:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-6bn-alabama-orforglipron-manufacturing-site/ 2025-12-10T10:20:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/formycon-zydus-fyb206-supply/ 2025-12-10T12:07:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ash-2025-golcadomide-rituximab-combo-r-r-fl/ 2025-12-10T09:15:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/bio-based-plastics-for-biopharma-how-is-parenteral-packaging-adopting-eco-design/ 2025-12-10T09:18:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-biogen-zurzuvae/ 2025-12-10T12:05:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biosecure-act-set-for-congress-vote-after-inclusion-in-annual-defence-bill/ 2025-12-11T10:25:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mirum-to-buy-bluejay-for-up-to-820m-in-rare-liver-disease-push/ 2025-12-09T13:42:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-gains-another-obesity-asset-with-2bn-deal-for-yaopharmas-glp-1ra/ 2025-12-09T13:26:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/bipolar-disorder-market-reach-9-4-across-7mm-2034/ 2025-12-09T12:39:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-ec-approval-gazyva/ 2025-12-09T10:42:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/inductive-bio-21m-arpah-funding/ 2025-12-09T09:29:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medical-bodies-sound-alarm-over-us-hepatitis-b-vaccine-vote/ 2025-12-08T15:24:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/viatris-definitive-agreements-biocon/ 2025-12-08T10:44:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agilent-monash-university-biodiscovery/ 2025-12-08T09:24:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cdc-acip-hepatitis-b-vaccination-policy/ 2025-12-05T18:05:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/utilizing-data-driven-insights-for-digital-health-solutions/ 2025-12-05T16:01:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/crescent-and-kelun-biotech-swap-cancer-asset-rights-in-double-deal/ 2025-12-05T13:36:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/denali-275m-royalty-pharma/ 2025-12-05T10:30:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-innovent-global-partnership/ 2026-02-05T15:19:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/second-round-drug-prices-ira-revealed/ 2025-12-04T17:27:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/former-fda-commissioners-unite-to-condemn-us-vaccine-proposals/ 2025-12-04T15:22:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-appoints-tracy-beth-hoeg-head-of-cder/ 2025-12-04T11:54:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/formosa-rxilient-agreement-app13007/ 2025-12-04T11:17:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-fda-approval/ 2025-12-04T10:31:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/richard-padzur-fda-cder-head-retirement/ 2025-12-03T11:47:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/win-pharma-in-uk/ 2025-12-03T11:28:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/agc-biologics-atum-partnership/ 2025-12-03T10:51:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/citizen-health-ucb-epilepsy/ 2025-12-03T09:37:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-primate-testing-draft-guidance-mab-2/ 2025-12-02T17:25:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-backs-use-of-glp-1ras-for-weight-loss-despite-shortage-warning/ 2025-12-02T16:48:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/regulatory-factors-in-rare-disease-studies/ 2025-12-02T16:21:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/house-passes-bill-that-reauthorises-the-fdas-paediatric-priority-voucher-pathway/ 2025-12-02T15:32:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/in-a-honduran-city-biotechs-create-gene-therapy-cocktails-to-fight-ageing/ 2025-12-02T14:04:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/oncology-trials-delivering-precision-and-reliability-in-data-management/ 2025-12-02T12:41:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/solid-sgt212-fda-status/ 2025-12-02T11:11:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/what-matters-in-the-api-market-as-2026-approaches/ 2026-02-12T16:49:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ckd-hpt-hp-hk-market-4bn-7mm-2034/ 2025-12-02T09:33:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lotus-nda-vizz-presbyopia/ 2025-12-02T09:06:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-and-us-strike-landmark-zero-tariff-pharma-deal/ 2025-12-01T17:25:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-tessera-aatd-tsra-196-development-commercialisation/ 2025-12-01T16:50:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sharp-funding-cuts-disrupt-prep-access-to-millions-of-hiv-patients/ 2025-12-01T15:33:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-pmda-approval-leqembi-japan/ 2025-12-01T11:17:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/potentially-groundbreaking-fda-gene-therapy-pathway-leaves-key-issues-unresolved-3/ 2025-12-01T10:20:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-armlupeg-injection/ 2025-12-01T09:29:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2025-west-pharmaceutical-synchrony-prefillable-syringe/ 2025-12-31T15:37:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-warns-of-immunisation-strategy-gaps-amid-measles-outbreaks/ 2025-11-28T16:41:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/celltrion-eylea-biosimilar-eydenzelt-health-canada-approval/ 2025-11-28T16:28:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/podcast-what-key-trends-are-people-talking-about-in-pharma/ 2025-11-28T12:07:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ecdc-european-hiv-aids-surveillance-report-2025/ 2025-11-28T11:43:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/iaso-bio-approval-fucaso/ 2025-11-28T11:28:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-approval-roche-inavolisib/ 2025-11-28T12:21:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/valneva-trims-rd-footprint-by-shutting-french-facility/ 2025-11-27T17:16:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sk-biopharmaceuticals-warf-radiopharmaceutical-licensing-deal/ 2025-11-27T11:39:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/beone-sonrotoclax-fda/ 2025-11-27T11:00:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/rare-disease-regulations-developing-asean/ 2025-11-27T09:48:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/physicians-growing-role-rwe-clinicial-trials-beyond/ 2025-11-27T09:26:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/corstasis-cvl-enbumyst-integration/ 2025-11-27T08:45:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/what-to-prioritise-transition-from-clinical-to-commercial-cgt/ 2025-11-27T16:45:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reeves-autumn-budget-targets-community-health-centres-and-nhs-tech-outlay-2/ 2025-11-26T17:48:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dupixent-gains-chronic-spontaneous-urticaria-indication-in-europe/ 2025-11-26T17:38:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/questions-on-how-new-ira-drug-prices-will-affect-mfn-agreements/ 2025-11-26T17:21:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-axes-550-jobs-at-swiss-manufacturing-site/ 2025-11-26T17:15:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/pushing-boundaries-in-cell-and-gene-therapy/ 2025-11-27T18:15:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/unicef-gavi-malaria-vaccine/ 2025-11-26T10:37:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-accelerated-approval-igan/ 2025-11-26T09:46:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-sciences-acquires-sprint-biosciences-oncology-trex1-programme/ 2025-11-25T16:53:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-developed-leukaemia-cell-therapy-to-be-offered-on-nhs/ 2025-11-25T15:02:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/veeva-commercial-summit-europe-2025-future-proofed-ai/ 2025-11-25T10:30:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/made-scientific-cellergy-clg001/ 2025-11-25T10:08:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-approval-fda-itvisma/ 2025-11-25T09:27:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-semaglutide-alzheimers-miss-phase-iii/ 2025-11-24T16:57:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/aseptic-filling-of-unstable-drug-products/ 2025-11-24T16:35:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-flies-the-pharma-flag-in-tech-heavy-1tn-market-cap-club/ 2025-11-24T15:59:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/navigating-the-fdas-import-operations-for-pharmaceuticals-and-biologics/ 2025-11-24T14:47:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/investors-bet-on-newer-technology-and-indications-for-cgts/ 2025-11-24T11:56:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-review-designations-adcs-2024/ 2026-02-05T15:12:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-biomanufacturing-maryland-investment/ 2025-11-24T14:06:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-rise-of-large-volume-injectors-patient-centric-innovation-in-biologics-delivery/ 2025-11-24T10:20:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vaximm-bcme-immunotherapy-platform/ 2025-11-24T10:53:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/galapagos-ceo-tightens-strategic-focus-in-pursuit-of-key-assets/ 2025-11-21T16:01:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reckless-and-harmful-experts-weigh-in-on-cdcs-autism-vaccine-link-stance/ 2025-11-21T12:02:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genscript-biotech-conference-2025-overcoming-cmc-barriers-cgt/ 2025-11-21T14:41:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aspen-parkinsons-therapy/ 2025-11-21T10:46:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-advanz-ec-approval/ 2025-11-21T09:18:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cphi-2025-linker-innovation-paves-the-way-for-a-wave-of-new-adcs/ 2026-02-03T16:43:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-kgaa-eyes-new-parkinsons-disease-assets-with-3bn-valo-partnership/ 2025-11-20T15:57:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-onshore-drug-facility/ 2025-11-20T13:54:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regenerons-eylea-franchise-boosted-by-pair-of-fda-approvals/ 2025-11-21T15:41:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-north-carolina-us-manufacturing-expansion/ 2025-11-20T14:53:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-tris-texas-adhd-allegations/ 2025-11-21T04:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-resurgence-of-mesenchymal-stem-cell-therapies/ 2025-11-20T12:00:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-lunsumio-ec-authorisation/ 2025-11-20T09:38:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alkermes-lundbeck-bidding-war-avadel-acquisition/ 2025-11-19T17:44:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arrowhead-nets-first-commercial-win-as-sirna-drug-garners-fda-approval/ 2025-11-19T16:52:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approval-abbvie-epkinly/ 2025-11-19T13:55:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/2025-acto/ 2025-12-31T15:37:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/csl-to-pump-1-5bn-into-us-plasma-supply-chain/ 2025-11-19T11:41:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/eco-design-shaping-the-future-of-pharma-packaging/ 2025-12-02T09:06:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/eleva-biologics-therapeutic-protein-manufacturing-interview/ 2025-11-19T17:36:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uspto-genprex-reqorsa/ 2025-11-19T10:22:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/insmed-receives-ec-approval/ 2025-11-19T09:09:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/redefining-clinical-trials-in-oncology-and-rare-diseases-across-the-europe/ 2025-11-19T09:48:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/fda-inspection-reveals-critical-supply-chain-vulnerabilities/ 2025-12-05T21:32:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/real-time-data-how-to-gain-an-edge-amid-clinical-services-consolidation/ 2025-12-05T21:57:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/solve-therapeutics-raises-120m-as-msd-joins-list-of-backers/ 2025-11-18T11:12:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merus-halozyme-petosemtamab-formulation/ 2025-11-18T10:30:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-halda-therapeutics-3-05bn/ 2025-11-18T09:53:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/shanghai-henlius-biotech-organon-perjeta-biosimilar-fda-approval/ 2025-11-17T17:14:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/high-dose-spinraza-set-for-eu-approval-despite-fda-setback-biogen/ 2025-11-17T16:45:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medicxi-unveils-e500m-fund-for-asset-centric-biotechs/ 2025-11-17T12:59:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-sarepta-elevidys-label/ 2025-11-17T15:22:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sofinnova-closes-e650m-healthcare-fund/ 2025-11-17T15:22:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-access-affordability/ 2025-11-14T18:19:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/raising-the-bar-can-higher-drug-spending-in-the-uk-deliver-for-pharma-and-patients/ 2025-11-18T16:20:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-bets-big-on-flu-antivirals-with-9-2bn-buyout-of-cidara/ 2025-11-14T15:24:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-and-novo-nordisk-disown-mangoceuticals-glp-1ra-partnership-claim/ 2025-11-14T12:00:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kura-oncology-kyowa-kirin-komzifti-fda-approval-rr-aml/ 2025-11-14T11:19:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/general-proximity-daiichi-sankyo-oncology/ 2025-11-14T10:34:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-biogen-mhra-leqembi-alzheimers/ 2025-11-14T09:23:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/estonias-digital-health-dna-trust-data-and-biotech-in-focus/ 2025-11-14T10:03:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/metagenomi-culls-25-of-its-workforce-and-replaces-ceo-in-reshuffle/ 2025-11-13T14:27:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-unveils-new-pathway-to-usher-bespoke-therapies-to-market/ 2025-11-13T12:05:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/europabio-calls-for-bold-approach-to-investment-amid-eu-biotech-act/ 2025-11-13T10:47:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cphi-2025-handprint-metric-bridges-pharma-sustainability-and-economic-value/ 2025-11-13T17:31:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chiesi-aliada-license-agreement-therapies/ 2025-11-13T10:28:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bostongene-kyoto-university-escc-development/ 2025-11-13T09:09:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sandoz-ceo-forecasts-a-q1-or-q2-market-entry-for-semaglutide-biosimilars-in-canada/ 2025-11-12T17:26:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/modulight-secures-12m-to-shine-precise-light-on-neurological-diseases/ 2025-11-12T14:04:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fdas-revolving-door-reveals-pazdur-as-new-cder-head/ 2025-11-12T11:48:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dyno-trisk-strategic-manufacturing-partnership/ 2025-11-12T11:00:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-rmat-march-bio-mb105/ 2025-11-12T09:59:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2025-gene-therapy-shows-potential-in-chronic-heart-failure/ 2025-11-11T20:55:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-calls-for-black-box-warning-to-be-removed-from-hrt-products/ 2025-11-11T18:26:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/sharp-invests-100-million-us-european-facilities/ 2025-11-12T09:10:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2025-vanquish-2-phase-overweight-t2d-2/ 2025-11-11T16:24:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2025-semaglutide-cardiovascular-risk-in-score-hf-study/ 2025-11-11T15:45:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lyell-rights-ict-cart-therapy/ 2025-11-11T13:46:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2025-amiloride-spironolactone-resistant-hypertension-control/ 2025-11-11T11:51:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2025-glucose-disposal-rate-heart-risk-t1d/ 2025-11-11T11:01:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aha-2025-sacubitril-valsartan-resistant-hypertension/ 2025-11-11T09:41:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-california-site-rlt-manufacturing/ 2025-11-11T10:06:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-keeps-up-ophthalmic-gene-therapy-push-with-475m-meiragtx-deal/ 2025-11-10T17:02:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/psychedelics-outside-mental-health/ 2025-11-10T14:12:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cphi-2025-directing-ai-driven-innovation-to-harness-europes-data-edge/ 2025-11-14T16:32:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/harbour-biomed-evinova-ai-biologics/ 2025-11-10T12:47:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-clinches-10bn-metsera-deal-as-novo-nordisk-retreats/ 2025-11-10T12:13:03+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pelthos-xepi-cream/ 2025-11-10T10:14:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanegenebio-lilly-rnai-licensing-deal/ 2025-11-10T09:55:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rhythm-forced-to-wait-for-imcivree-expansion-as-fda-delays-decision/ 2025-11-07T16:08:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-darzalex-faspro-smouldering-multiple-myeloma-fda-approval/ 2025-11-07T15:00:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-hits-long-term-pledge-as-us-prices-of-weight-loss-drugs-slashed/ 2025-11-07T12:22:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/trace-level-detection-in-gas-chromatography-analysis/ 2025-11-10T16:17:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abzena-mabqi-drug-development-solution/ 2025-11-07T10:59:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-advanz-mhra-authorisations-gobivaz/ 2025-11-07T10:15:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jjs-caplyta-wins-mdd-approval-to-extend-revenue-horizon/ 2025-11-06T16:35:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/former-blockbuster-linzess-grows-label-with-paediatric-ibs-c-approval/ 2025-11-06T11:36:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisks-oral-wegovy-reduces-cardiovascular-risk-factors-in-obesity/ 2025-11-06T10:49:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cencora-1bn-us-pharma-expansion/ 2025-11-06T10:52:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/leukogene-fda-status-m2tcd33/ 2025-11-06T09:26:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-latest-outlook-trim-shows-quick-momentum-loss/ 2025-11-05T17:12:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/veeva-commercial-summit-2025-agentic-ai/ 2025-11-05T17:04:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avant-sgaustria-jv-develop-therapy/ 2025-11-05T15:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-latest-regulatory-updates-affecting-parenteral-packaging/ 2025-11-05T13:42:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/innovation-meets-convenience-redefining-lyophilized-drug-delivery-for-patients/ 2025-11-10T09:55:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/sri-lanka-drug-pricing-reform/ 2025-11-05T11:48:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-and-pfizers-bidding-war-for-metsera-escalates-despite-legal-threats/ 2025-11-05T11:02:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-secures-700m-for-broad-cancer-adc-asset/ 2025-11-05T10:52:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amacathera-pacira-sign-agreement-amt-143/ 2025-11-05T10:21:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-cdr-life-licensing-deal-autoimmune/ 2025-11-05T10:19:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-halts-uniqures-plans-for-huntingtons-disease-gene-therapy/ 2025-11-04T18:00:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tidmarshs-fda-exit-marks-latest-high-profile-jockeying-at-us-agencies/ 2025-11-04T17:04:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/top-20-biopharma-market-cap-up-q3-2025/ 2025-11-04T15:28:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/viiv-healthcare-launches-risk-to-reasons-initiative-in-the-uk-to-empower-women-to-take-control-of-their-hiv-prevention-choices/ 2025-11-04T13:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kimberly-clark-buys-troubled-tylenol-maker-kenvue-for-48-7bn/ 2025-11-04T11:25:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ucb-kygevvi-fda/ 2025-11-04T11:44:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-dutch-facility/ 2025-11-04T09:08:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ai-breakthrough-prostate-cancer-diagnosis/ 2025-11-04T08:29:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alvotech-faces-fda-setback-for-its-simponi-biosimilar-avt05/ 2025-11-04T04:33:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-novo-nordisk-metsera-acquisition-lawsuit/ 2025-11-03T11:44:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2025-sichaun-kelun-breast-cancer-adc/ 2025-11-03T11:35:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2025-bayer-bi-her2-nsclc/ 2025-11-03T10:35:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/intocell-xcellon-adc/ 2025-11-03T10:32:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/4dmt-otsuka-apac/ 2025-11-03T10:02:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sensei-to-ditch-its-lead-candidate-and-cut-workforce-amidst-strategic-review/ 2025-10-31T17:32:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/epioxa-keratoconus-redefines-treatment-decade-long-wait/ 2025-10-31T13:36:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-next-gen-medical-textiles-combine-comfort-safety-and-sustainability/ 2025-12-08T09:44:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/massive-sales-for-weight-loss-drugs-spur-eli-lillys-q3/ 2025-10-31T11:03:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/debiopharm-nettargets-adcs/ 2025-10-31T09:39:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/helex-3-5m-funding-kidney-therapies/ 2025-10-31T09:26:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-astrazeneca/ 2025-10-30T17:36:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-biosimilar-approval-draft-guidance-2025/ 2025-10-30T16:55:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/magazine-cleanroom-chronicles/ 2025-10-30T15:41:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-locks-horns-with-pfizer-in-late-bid-for-metsera/ 2025-10-30T14:24:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-ramps-up-orforglipron-production-with-1-2bn-puerto-rico-site-expansion/ 2025-10-30T11:07:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dewpoint-fda-drug-designation-dptx3186/ 2025-10-30T10:05:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/from-pilot-to-production-scaling-lyophilization-with-confidence/ 2025-10-30T09:52:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/pfizer-roche-place-10bn-bets-obesity-liver-disease-therapies-trump-grip-drug-pricing-manufacturing/ 2025-10-30T09:32:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/seres-ser-155/ 2025-10-30T10:07:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/elevara-explores-cdk4-6-inhibition-for-the-treatment-of-rheumatoid-arthritis/ 2025-10-31T09:44:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-and-nvidia-to-build-pharmas-most-powerful-supercomputer/ 2025-10-29T17:25:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cphi-2025-time-for-european-biopharma-to-double-down-on-innovation/ 2025-10-29T14:22:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-rejects-regenerons-eylea-hd-amid-filling-facility-woes/ 2025-10-29T11:51:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-empirico-sirna-licensing-deal-745m-copd/ 2025-10-29T11:17:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aldeyra-reshuffles-pipeline-culling-asset-despite-phase-ii-success/ 2025-10-29T11:18:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/esmo-2025-data-decisions-and-the-future-of-oncology/ 2025-10-29T14:53:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kyowa-orchard-mld/ 2025-10-29T13:06:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lifecore-polypeptide-us-peptide-manufacturing/ 2025-10-29T09:56:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/threshold-debate-norway/ 2025-11-07T15:20:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/glp-1ra-microdosing-trend-continues-despite-anecdotal-evidence/ 2025-10-28T16:17:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-managing-complexities-and-challenges-in-early-phase-clinical-trials/ 2025-10-29T10:03:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/companies-in-all-sectors-should-pay-constant-attention-to-geopolitics-analysis/ 2025-11-12T10:48:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-q3-new-drugs-step-up-as-generics-squeeze-entresto/ 2025-10-28T11:42:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/turning-bottlenecks-into-breakthroughs-in-gene-therapy-manufacturing/ 2025-10-29T14:17:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hemab-bleeding-disorder/ 2025-10-28T09:59:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-fda-approval-winrevair/ 2025-10-28T09:58:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/organon-ceo-steps-down-sales-malpractice-probe/ 2025-10-27T16:40:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/guardant-and-zephyr-ai-pair-up-to-advance-cancer-biomarker-development/ 2025-10-27T16:21:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/improving-vaccine-outreach-and-education-with-real-world-data/ 2025-10-27T17:35:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-targets-syndivias-prostate-cancer-adc-in-268m-buy/ 2025-10-27T15:23:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-buys-adverum-in-eye-disease-gene-therapy-punt/ 2025-10-27T11:16:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/excellergy-eyes-ige-therapy-space-as-xolair-nears-patent-expiry/ 2025-10-27T10:46:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chugai-renalys-kidney/ 2025-10-27T10:37:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-agreement-avidity-12bn/ 2025-10-27T08:57:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mhra-illegal-glp-1ra-weight-loss-manufacturing-facility-shut-down/ 2025-10-24T15:29:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/dupixent-stirs-sanofis-growth-as-vaccine-sales-cool/ 2025-10-24T14:33:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-and-incyte-to-seek-approval-of-alopecia-jak-inhibitor-in-children/ 2025-10-24T14:38:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/galderma-outlays-650m-for-us-manufacturing-as-nemluvio-sales-soar/ 2025-10-24T10:44:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/euroapi-med4cure-project-pharma-sovereignty/ 2025-10-24T11:13:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsks-blenrep-fda-approval-myeloma/ 2025-10-24T10:18:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/demystifying-the-immune-system-with-the-help-of-ai-ml/ 2025-11-10T19:59:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-in-ongoing-discussions-with-us-government-over-drug-pricing-ceo-says/ 2025-10-23T15:53:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/biotech-recovery-q3-2025-venture-funding/ 2025-10-23T15:15:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-innovent-oncology-licensing-deal-11-4bn-adc-bispecifics/ 2025-10-27T08:48:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/remote-monitoring-the-tech-enhancing-diabetes-management-in-scotland/ 2025-12-08T06:04:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ipsen-imcheck-therapeutics/ 2025-10-23T10:07:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biotechs-brush-off-sector-headwinds-in-venture-financing-rebound/ 2025-10-23T09:35:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/alkermes-avadel-2-1bn/ 2025-10-23T09:39:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-future-of-high-potency-apis-strategies-for-manufacturing-challenges/ 2026-02-13T12:20:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/adcs-a-primer-for-the-pharmaceutical-industry/ 2026-02-12T16:51:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/galapagos-to-shutter-cell-and-gene-therapy-unit/ 2025-11-21T15:37:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2025-hengrui-immunotherapy-combo-hcc/ 2025-10-22T10:51:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-board-members-step-down/ 2025-10-22T10:38:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/ich-e6-r3-transforming-quality-management-for-cgt-trials/ 2025-10-22T14:40:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ventus-genentech-small-molecule/ 2025-10-22T09:55:25+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/oximio-welcomes-canadas-bay-area-research-logistics-to-expand-global-reach-and-services/ 2025-10-22T09:03:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/health-canada-approves-gilead-lyvdelzi/ 2025-10-22T08:14:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gibson-dunn-crutcher-white-case-top-mea-legal-advisers-in-q1-q3-2025/ 2025-10-21T17:21:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-precem-tct-colorectal-cancer-phase-i-esmo-2/ 2026-02-03T16:44:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/from-the-experts-how-to-successfully-implement-annex-1-regulations/ 2025-10-21T14:40:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/aao2025-eyp-1901-promise-dme-wamd/ 2025-10-21T14:09:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-3bn-virginia-manufacturing-facility/ 2025-10-21T11:29:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lundbeck-contera-ligonucleotide-based-medicines/ 2025-10-21T10:14:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/from-creams-to-biologics-adapting-dermatology-trials-to-new-therapies/ 2025-10-23T17:16:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/biotech-to-boardroom-how-early-oncology-data-builds-investor-confidence/ 2025-10-21T08:58:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roches-gazyva-approval-fda-lupusnephritis/ 2025-10-21T10:08:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-glaukos-epioxa-as-incision-free-corneal-disease-treatment/ 2025-10-20T14:12:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-rybrevant-head-neck-cancer-phase-ib-ii/ 2025-10-20T14:07:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/infertility-treatment-heads-first-drugs-on-fdas-new-priority-review-scheme/ 2025-10-20T13:59:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-greenlight-for-roche-alzheimer-disease-test-sparks-care-paradigm-shift-2/ 2025-10-20T10:12:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-verzenio-hr-her2-breast-cancer-os-phase-iii/ 2025-10-20T10:02:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo-2025-novartis-pluvicto-end-stage-mhspc/ 2025-10-20T09:32:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo25-keytruda-combo-defies-doubt-delivers-pfs-and-os-gains-in-ovarian-cancer/ 2025-10-20T02:21:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/esmo25-padcev-keytruda-combo-has-potential-as-new-soc-for-perioperative-bladder-cancer/ 2025-10-21T20:23:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/skadden-and-veirano-lead-legal-advisers-in-south-central-america-for-q1-q3-2025/ 2025-10-21T17:21:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jp-morgan-rothschild-lead-financial-advisers-of-mea-region-in-q1-q3-2025/ 2025-10-21T17:20:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/morgan-stanley-clairfield-international-lead-financial-advisers-in-south-central-america-for-q1-q3-2025/ 2025-10-21T17:20:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/aam-generic-biosimilar-medicine-us-drug-pricing/ 2025-10-17T10:37:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/adcytherix-adc-development/ 2025-10-17T09:29:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/emd-serono-us-ivf-therapy/ 2025-10-17T07:36:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/wachtell-kirkland-emerge-top-north-american-ma-legal-advisory-during-q1-q3-2025/ 2025-10-20T13:21:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/goldman-sachs-houlihan-lokey-lead-north-america-ma-advisory-during-q1-q3-2025/ 2025-10-20T13:21:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ao-shearman-and-cms-top-europe-ma-legal-advisory-rankings-for-q1-q3-2025/ 2025-10-20T13:21:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-doubles-lokelma-output-with-445m-texas-plant-expansion/ 2025-10-16T15:26:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-acquires-zaltenibart-omeros-pnh-asset/ 2025-10-17T07:47:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/goldman-sachs-ubs-emerge-top-asia-pacific-ma-financial-advisers-during-q1-q3-2025/ 2025-10-20T13:20:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/paul-hastings-trilegal-emerge-top-asia-pacific-ma-legal-advisers-during-q1-q3-2025/ 2025-10-20T13:20:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bank-of-america-rothschild-co-dominate-q1-q3-2025-european-ma-advisory/ 2025-10-20T13:20:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/from-nobel-to-next-gen-swedens-quiet-life-sciences-ascent/ 2025-10-16T11:00:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavarian-nordics-shareholders-and-board-in-standoff-amid-takeover-offer/ 2025-10-16T10:04:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tubulis-closes-series-c/ 2025-10-16T09:48:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oceanpine-equity-stake-jacoray/ 2025-10-16T07:38:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-neurological-disorder-burden-alzheimers/ 2025-10-15T16:18:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kirkland-ellis-dominates-ma-legal-advisory-in-first-three-quarters-of-2025/ 2025-10-15T13:22:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/goldman-sachs-and-houlihan-lokey-lead-in-ma-advisory-for-q1-q3-2025/ 2025-10-15T13:18:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-tukysa-phase-iii-her2-breast-cancer-maintenance-trial/ 2025-10-15T11:00:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nabla-takeda-protein-therapeutics-design/ 2025-10-15T10:14:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biocryst-buys-astria/ 2025-10-26T16:38:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-q3-financial-results-orthopaedic-spinoff/ 2025-10-15T07:57:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kailera-nets-600m-to-power-phase-iii-launch-of-obesity-drug/ 2025-10-14T15:02:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinas-drugs-offer-lifeline-for-global-pharma-as-it-peers-over-the-patent-cliff/ 2025-10-14T14:57:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-abbvies-rinvoq-bowel-disease/ 2025-10-14T10:29:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/from-strategy-to-submission-how-your-cro-should-create-value-beyond-execution/ 2025-10-14T09:15:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/palisade-pali-2108/ 2025-10-14T09:30:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/advanced-bioconjugation-strategies-new-webinar-tackles-complex-chemistry-for-targeted-therapeutics/ 2025-10-14T15:43:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/new-us-biotech-hubs-showing-potential-amid-onshoring-request/ 2025-10-30T17:57:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biosecure-returns-to-us-pharma-agenda-with-2-0-update/ 2025-10-13T11:56:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-trump-mfn-drug-pricing-deal/ 2025-10-13T13:07:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/jj-protagonist-therapeutics/ 2025-10-13T11:02:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/teva-medincell-fda/ 2025-10-13T11:12:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/fda-green-list-flagging-illegal-glp-1ra-compounders-is-long-overdue/ 2025-10-10T21:17:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/podcast-the-fdas-emerging-aversion-to-advisory-committees/ 2025-10-10T16:48:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-expands-car-t-portfolio-with-1-5bn-orbital-buyout/ 2025-10-10T16:28:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-4-5bn-virginia-api-manufacturing-facility/ 2025-10-10T10:28:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/flu-vaccine-uptake-increases-28-in-england/ 2025-10-10T10:25:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-eydenzelt-eye-diseases/ 2025-10-10T10:48:29+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharma-rd-set-to-endure-despite-rising-mfn-costs/ 2026-02-02T17:57:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/turbine-astrazeneca-adc-partnership/ 2025-10-10T11:09:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-ingelheim-nerandomalist-ipf-fda-approval/ 2025-10-09T15:39:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-buys-mash-specialist-akero-for-up-to-5-2bn/ 2025-10-09T13:08:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amazon-pharmacy-kiosks-to-provide-prescription-medications-in-minutes/ 2025-10-09T11:06:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/arthrosi-gout-therapy/ 2025-10-09T10:51:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-libtayo-cscc/ 2025-10-09T10:51:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/excellence-awards/featured-company/eschbach-shiftconnector-operational-intelligence-ai-innovation/ 2025-12-31T15:37:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/china-accounts-for-one-fifth-of-global-drugs-in-development/ 2025-12-16T14:29:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/performance-health-doubles-fulfilment-efficiency-with-ocado-robots/ 2025-10-10T09:51:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/peter-marks-ex-fda-joins-eli-lilly/ 2025-10-08T13:44:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/maplights-251m-ipo-sees-schizophrenia-drug-developers-on-top/ 2025-10-08T10:45:54+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/affinia-gene-therapy/ 2025-10-08T11:33:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oragenics-receptor-ai-brain/ 2025-10-08T11:34:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/demonstrating-the-importance-of-electronic-data-capture-edc-setup-times/ 2025-11-14T17:59:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cdc-immunisation-schedule-update-covid-19-mmr-varicella/ 2025-10-07T15:53:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lillys-omvoh-benefit-continues-for-four-years-in-uc/ 2025-10-07T15:28:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nanophoria-hfref-treatment/ 2025-10-07T11:03:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-lifts-clinical-hold-on-neurizons-als-drug/ 2025-10-07T12:25:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/venture-financing-mrna-vaccines-declines-2025-ytd/ 2025-10-07T09:14:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chiesi-arbor-gene-editing-programme/ 2025-10-07T11:03:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-daiichi-sankyo-datroway-phase-iii-tropion-breast02/ 2025-10-07T08:05:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/induced-pluripotent-stem-cells-the-advantages-challenges-and-advances/ 2025-12-02T13:00:37+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/funds-dry-up-for-mrna-vaccines-amid-us-political-storm/ 2025-10-06T14:26:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-cdms-support-services-can-make-or-break-complex-study-rescues/ 2025-10-08T13:42:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-pilot-anda-programme-generics-biosimilars/ 2025-10-07T15:41:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trogenix-lands-95m-series-a-backed-by-eli-lilly-for-brain-cancer-therapy/ 2025-10-06T11:01:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mcmaster-mit-antibiotic/ 2025-10-06T10:48:43+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/santhera-agamree-dmd/ 2025-10-06T10:48:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-jazz-tecentriq-zepzelca-es-sclc-fda-approval/ 2025-10-03T16:23:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/trump-administration-mfn-drug-pricing-deal-pfizer/ 2025-10-03T15:33:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/rocket-ditches-blood-disorder-gene-therapy-in-ongoing-pipeline-pivot/ 2025-10-03T14:33:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-approves-mifepristone-generic-as-political-abortion-war-rages-on/ 2025-10-03T15:06:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgens-phase-iii-data-supports-fda-label-expansion-of-repatha/ 2025-10-03T10:51:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/takeda-cell-therapy-discontinuation/ 2025-10-03T13:25:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/five-key-insights-to-unlock-the-secrets-behind-a-successful-commercial-drug-launch/ 2025-10-29T16:12:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/advancing-lifechanging-medicine-grna-in-the-spotlight/ 2025-10-02T14:31:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-govenment-shutdown-fda-impact/ 2025-10-02T10:42:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/halozyme-eyes-microparticles-in-900m-elektrofi-acquisition/ 2025-10-02T10:25:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/huaweis-three-key-steps-to-drive-industrial-intelligence-forward-and-unleash-ais-full-potential/ 2025-10-02T10:26:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-leaders-are-acting-political-says-ex-agency-chief-counsel/ 2025-10-02T08:31:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/digital-first-in-silico-models-join-the-bioprocess-revolution/ 2025-10-02T15:01:22+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cutting-through-the-hype-optimising-ai-in-clinical-data/ 2025-10-01T15:41:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-70m-us-bioresearch-manufacturing-site-expansion/ 2025-10-01T14:37:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/orphan-drug-landscape-7mm/ 2025-10-01T13:51:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/the-road-to-accessible-car-t-therapies-inside-a-world-first-innovation-for-decentralised-leukapheresis/ 2025-10-01T13:38:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-government-shuts-down-over-funding-impasse/ 2025-10-01T10:42:10+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-shakes-hands-with-white-house-on-drug-discounts-under-mfn-programme/ 2025-10-01T12:37:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/klotho-turn-assets/ 2025-10-01T11:16:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/star-therapeutics-series-d-funding/ 2025-10-01T11:16:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/disruption-due-for-long-held-assumptions-in-biopharma-says-bia-chair/ 2025-09-30T20:27:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/newco-licensing-models-are-tipping-deals-in-favour-of-chinas-biotechs/ 2025-09-30T16:20:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ers-2025-long-term-cftr-clinical-benefit-microbial-impact/ 2025-09-30T15:04:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/johnson-johnson-tremfya-paediatric-psoriasis-fda-approval/ 2025-09-30T10:35:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisai-biogen-leqembi/ 2025-09-30T11:00:30+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/oral-liquid-dosage-forms-emerging-trends-and-key-challenges/ 2025-09-30T09:36:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/ers-2025-apg808-biologic-moderate-asthma/ 2025-10-01T08:56:12+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/genmab-acquires-merus/ 2025-09-30T11:00:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/first-responders-see-ai-and-other-advanced-tech-as-essential/ 2025-09-29T16:26:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/how-to-build-flexibility-into-your-cgt-manufacturing-process/ 2025-09-30T12:33:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/comment/the-dangerous-second-life-of-medical-waste/ 2025-09-29T10:05:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/regeneron-evkeeza-hofh/ 2025-09-29T10:38:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-us-manufacturing/ 2025-09-29T10:39:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-launches-dtc-platform-amid-us-pricing-pressures/ 2025-09-26T15:43:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/the-baltics-a-region-punching-above-its-weight-on-the-global-life-sciences-stage/ 2025-09-26T11:22:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/drugmakers-point-to-us-expansion-plans-amid-trumps-100-drug-tariff/ 2025-09-26T13:55:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/european-pe-company-prioritising-cgt-and-other-novel-modality-investments/ 2025-09-26T11:03:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/synaffix-qurient-licensing-dual-payload-adc/ 2025-09-26T10:43:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-lillys-inluriyo-advanced-breast-cancer/ 2025-09-26T10:39:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/harmonys-cannabidiol-drug-flops-in-pivotal-fragile-x-syndrome-trial/ 2025-10-08T16:04:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-pays-up-to-nearly-600m-for-evaxions-mystery-vaccine-candidate/ 2025-09-25T15:35:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bms-direct-to-consumer-sotyktu-expansion/ 2025-09-26T10:45:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/basilea-in-line-for-159m-of-us-federal-funding-for-uti-antibiotic-pill/ 2025-09-25T10:52:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uniqure-huntingtons-disease-amt-130-phase-i-ii/ 2025-09-25T10:57:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/moderna-vaccine-facility-uk/ 2025-09-25T10:19:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-625m-venture-capital-arm/ 2025-09-25T09:56:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-bids-to-broaden-ms-pipeline-and-strengthen-ocrevus-influence/ 2025-10-08T15:33:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/podcast-how-oral-glp-1ras-are-set-to-impact-the-obesity-market/ 2025-09-24T16:43:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogen-spinraza-high-dose-fda-rejection/ 2025-09-24T15:50:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-delays-approval-decision-for-sanofis-ms-treatment-tolebrutinib/ 2025-09-24T13:50:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-to-build-6-5bn-orforglipron-production-site-in-texas/ 2025-09-24T10:41:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/enhertu-combo-fda-priority-review/ 2025-09-24T10:45:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/tegmine-boehringer-ingelheim-partnership/ 2025-09-24T10:45:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/imunons-phase-iii-stage-il-12-gene-therapy-alters-tumour-microenvironment-in-ovarian-cancer/ 2025-09-25T17:30:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-tylenol-label-leucovorin-autism-approval/ 2025-09-23T15:40:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/novo-nordisk-leads-mash-therapeutic-race/ 2025-09-23T14:20:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-approval-recurrent-respiratory-papillomatosis/ 2025-09-23T13:50:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/alirocumab-reduces-ischemic-events-mortality-ascvd/ 2025-09-23T13:36:20+00:00 daily 0.2 https://www.pharmaceutical-technology.com/interviews/can-oral-glp-1ras-deliver-on-the-promise-of-accessible-obesity-care/ 2025-09-23T13:15:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bill-gates-pledges-912m-to-combat-infectious-diseases-amid-us-funding-cuts/ 2025-09-23T10:32:48+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/innovative-mental-health-treatment-tech-struggles-for-traction-as-pharma-dominates/ 2025-09-23T10:29:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/merck-siemens-extend-partnership/ 2025-09-23T10:25:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/pharmaceutical-technology-october/ 2025-09-23T11:17:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eu-servier-voranigo-idh-mutant-glioma/ 2025-09-23T10:25:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-keytruda-qlex-subcutaenous-fda-approval/ 2025-09-22T15:52:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/pfizer-buys-monthly-glp-1ra-developer-metsera-for-4-9bn/ 2025-09-23T13:46:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/stealth-bios-forzinity-finally-approved-as-first-barth-syndrome-therapy/ 2025-09-22T10:26:07+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/vpag-stalemate-uk-pharma/ 2025-09-22T09:24:47+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ionis-sobis-tryngolza-eu-approval/ 2025-09-22T12:41:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astellas-izervay-approval-ga/ 2025-09-22T12:41:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/what-does-the-eu-data-act-mean-for-businesses/ 2025-09-19T10:56:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bluebird-bio-flies-to-pastures-new-with-genetix-rebranding/ 2025-09-25T11:58:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/business-concerns-about-tariffs-continue-to-rise-3/ 2025-09-19T10:49:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-reflecting-on-2025-trend-predictions/ 2025-10-22T08:34:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fujifilm-biotechnologies-argenx/ 2025-09-19T11:22:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/vectory-shape-aav-capsid/ 2025-09-19T07:17:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/fda-hae-drought-record-year-approvals/ 2025-09-18T14:30:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/easd-2025-na-931-obese-patients/ 2025-09-18T13:43:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/biogens-zurzuvae-approved-as-first-postpartum-depression-drug-in-europe/ 2025-09-18T11:58:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/roche-signs-agreement-to-acquire-89bio/ 2025-09-18T12:02:50+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/as-us-funding-falters-mrna-cancer-vaccine-pioneers-face-new-hurdles/ 2025-09-18T10:46:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/easd-2025-mir-155-upregulation-pancreas-t1d-targets/ 2025-09-18T09:52:33+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/easd-2025-redefine-2-trial-unveils-meaningful-weight-reduction-cagrisema/ 2025-09-18T09:48:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/easd-2025-viperin-path-targeted-beta%e2%80%91cell-preservation-in-t1d/ 2025-09-18T09:27:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mabwell-aditum-launch-kalexo-bio/ 2025-09-18T08:39:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/easd-2025-early-uk-screening-td1/ 2025-09-18T07:59:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/easd-2025-sab-142-phase-i-data-t1d/ 2025-09-18T07:42:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/big-pharma-companies-hit-with-fda-warning-letters-in-drug-ad-clampdown/ 2025-09-17T16:19:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/easd-2025-zimislecel-infusion-insulin-t1d/ 2025-09-18T09:24:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/solving-global-cdmo-challenges-indena-and-tcg-greenchems-strategic-alliance/ 2026-02-13T12:10:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eli-lilly-picks-virginia-for-5bn-drug-manufacturing-plant/ 2025-09-17T10:31:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/varmx-csl-blood-coagulation/ 2025-09-17T12:57:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gsk-plans-30bn-investment-rd-us/ 2025-09-17T12:56:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/reunion-neuroscience-expands-series-a-to-133m-after-positive-trial-milestones/ 2025-09-18T09:10:42+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/european-society-of-cardiology-esc-annual-meeting-2025/ 2025-09-17T13:11:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-ema-approval-rybelsus-label/ 2025-09-16T13:32:05+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/atyr-pharma-stock-crashes-on-phase-iii-pulmonary-sarcoidosis-fail/ 2025-09-16T10:25:06+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/cadrenal-therapeutics-acquires-exitheras-factor-xia/ 2025-09-16T13:31:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-returns-to-monte-rosa-for-second-time-in-a-year-with-5-7bn-deal/ 2025-09-15T15:31:32+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/podcast-how-rwd-furthers-understanding-of-pregnancy/ 2025-09-16T14:05:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/astrazeneca-halts-200m-research-investment-in-cambridge/ 2025-09-17T00:23:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-chief-blames-decades-of-regulatory-failure-for-misleading-pharma-ads/ 2025-09-15T10:28:14+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amneal-secures-fda-approval-sodium-oxybate-solution/ 2025-09-15T08:29:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lb-pharmaceuticals-tops-2025-biotech-ipo-list-with-285m-nasdaq-debut/ 2025-09-12T15:26:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/features/podcast-key-trials-and-trends-from-esc-congress-2025/ 2025-09-12T11:16:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-extends-rinvoq-exclusivity-by-four-years-after-generics-settlements/ 2025-09-12T10:26:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kashiv-cristalia-biosimilar/ 2025-09-15T04:11:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/zentiva-gtcr-generic-drug-maker/ 2025-09-15T04:09:31+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/msd-calls-off-1bn-uk-expansion/ 2025-09-11T16:28:18+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/uk-pharma-industry-risks-losing-world-leading-status-as-investment-plummets/ 2025-09-11T10:44:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kriya-therapeutics-gene-therapy/ 2025-09-11T12:35:59+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/sanofi-tzield-t1d/ 2025-09-11T12:34:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/top-20-biopharma-market-capss-fall/ 2025-09-10T15:17:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-tasks-fda-to-crack-down-on-misleading-drug-advertising/ 2025-09-10T14:05:58+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/capricor-statement-fda-deramiocel-rejection/ 2025-09-10T10:43:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novo-nordisk-slashes-11-of-workforce-as-eli-lilly-pressure-tightens/ 2025-09-10T10:42:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/kytopen-bluewhale-bio/ 2025-09-10T09:00:41+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/medison-ipsen-bylvay/ 2025-09-10T07:47:21+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-acquires-tourmaline-bio-ascvd-pacibekitug/ 2025-09-09T15:27:45+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/us-government-signs-56m-smallpox-mpox-vaccine-order-despite-political-disarray/ 2025-09-09T15:10:57+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novos-ozempic-price-cut-expected-to-slow-market-share-erosion/ 2025-09-09T10:30:01+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/lilly-to-seek-jaypirca-label-expansion-for-first-line-cll-sll-usage/ 2025-09-09T10:38:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/servier-fragile-x-kaerus/ 2025-09-09T10:00:02+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/epigenic-epigenetic-treatment/ 2025-09-09T07:39:44+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-glp-1ra-diabetes-obesity-drugs-essential-medicines/ 2025-09-08T16:59:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/md-anderson-phoenix-cell-and-gene/ 2025-09-08T10:13:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/hengrui-braveheart-hrs-1893/ 2025-09-09T07:52:19+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/cystic-fibrosis-market-2034-7mm/ 2025-09-05T13:17:26+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/comparator-sourcing-essential-information-for-oximio/ 2025-09-05T11:24:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/multiply-labs-biomanufacturing-robot-to-slash-cell-therapy-costs/ 2025-09-10T14:22:09+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/five-takeaway-quotes-from-rfk-jrs-combative-senate-hearing/ 2025-09-05T10:02:11+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/ema-warns-of-rise-in-illegal-weight-loss-drugs-marketed-online/ 2025-09-05T09:44:04+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/mrm-health-pipeline/ 2025-09-05T09:26:52+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/gilead-us-hiv/ 2025-09-05T08:00:53+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/bavaria-nordic-vimkunya-uk-launch/ 2025-09-04T16:47:36+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/choosing-the-right-fill-finish-cdmo-for-small-scale-batches/ 2025-09-04T14:45:15+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/fda-creates-new-pathway-for-rare-disease-drugs-analysts-unconvinced/ 2025-09-05T16:29:38+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/insmed-win-bronchiectasis-fda-approval-brinsupri/ 2025-09-04T12:42:51+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-adds-again-to-sirna-pipeline-with-second-deal-in-a-day/ 2025-09-04T09:35:46+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/avadel-valiloxybate-rights/ 2025-09-04T09:23:34+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/abbvie-elahere-ovarian-cancer/ 2025-09-04T08:05:27+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/who-calls-for-mental-health-action-as-global-cases-reach-one-billion/ 2025-09-03T16:20:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/analyst-comment/morocco-sweeping-pharmaceutical-pricing-reform/ 2025-09-16T15:37:13+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/six-key-steps-to-successful-technical-transfers-of-high-potent-oral-solid-dose-drugs/ 2025-09-03T13:24:23+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/transformation-with-real-world-evidence-rwe/ 2025-09-04T09:50:55+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/novartis-returns-to-alpha-synuclein-with-2-2bn-arrowhead-deal/ 2025-09-03T10:35:17+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/quotient-sciences-cpi-rna-therapy/ 2025-09-03T09:19:40+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/amgen-science-and-innovation-hub/ 2025-09-03T07:50:16+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/chinese-drugmakers-prep-for-looming-semaglutide-generics-horizon/ 2025-09-02T15:03:39+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/trump-blames-covid-19-drugmakers-for-fuelling-cdc-turmoil/ 2025-09-02T10:37:08+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/nvidia-backed-charm-secures-80m-to-advance-aml-drug/ 2025-09-02T10:17:24+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/oxford-ellison-ai-vaccine-research/ 2025-09-02T10:08:49+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/boehringer-nsclc-nmpa/ 2025-09-02T07:41:35+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/capvest-to-buy-control-of-generics-giant-stada-in-e10bn-deal/ 2025-09-01T15:27:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/cdmo-insights-podcast-series-our-experience-is-your-strength-episode-5-sustainable-packaging/ 2025-09-01T13:13:28+00:00 daily 0.2 https://www.pharmaceutical-technology.com/sponsored/advancing-diagnostics-reagent-development-for-emerging-and-rare-diseases/ 2025-09-01T12:59:56+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/esc-2025-novo-nordisks-wegovy-superior-to-zepbound-in-reducing-cv-events/ 2025-09-01T11:01:00+00:00 daily 0.2 https://www.pharmaceutical-technology.com/news/eisais-leqembi-unlocks-at-home-dosing-with-fda-autoinjector-approval/ 2025-09-02T08:23:39+00:00 daily 0.2